Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at BrightSpring Health Services (NASDAQ:BTSG) and its peers.
Addus HomeCare has gotten torched over the last six months - since September 2024, its stock price has dropped 26.9% to $95.71 per share. This may have investors wondering how to approach the situation.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Option Care Health (NASDAQ:OPCH) and its peers.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including Pediatrix Medical Group (NYSE:MD) and its peers.
Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG)
will be announcing earnings results tomorrow before market open. Here’s what to expect.
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 7.5% year on year to $297.1 million. Its non-GAAP profit of $1.38 per share was 1.6% above analysts’ consensus estimates.
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Brookdale (NYSE:BKD) and its peers.
Looking back on senior health, home health & hospice stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Chemed (NYSE:CHE) and its peers.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at senior health, home health & hospice stocks, starting with BrightSpring Health Services (NASDAQ:BTSG).
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice industry, including Addus HomeCare (NASDAQ:ADUS) and its peers.
